Q1 Financial Results 2025-26

AI SummaryClose X

Beximco Pharmaceuticals PLC reported strong first-quarter results for the period ending September 30, 2025, with net revenue increasing by 17.8% to BDT 13,794.8 million (£85.0 million), driven by a 17.8% rise in domestic sales to BDT 13,717.4 million (£84.5 million) and a 5.4% increase in export sales to BDT 77.4 million (£0.5 million). Profit after tax saw a significant jump of 41.9%, reaching BDT 2,401.3 million (£14.8 million) compared to BDT 1,691.9 million (£10.7 million) in the prior year's comparable period.

Disclaimer*

UK 100

Latest directors dealings